| 121688 |
CLINICAL MEDICINE : JOURNAL OF THE ROYAL COLLEGE OF PHYSICIANS OF LONDON |
The RCP should support the statutory regulation of herbal practitioners |
2013-02-01 |
10.7861/clinmedicine.13-1-114a |
Mcintyre M., Flower A. |
| 121687 |
ONCOIMMUNOLOGY |
CD56 marks human dendritic cell subsets with cytotoxic potential. |
2013-02-01 |
10.4161/onci.23037 |
Roothans Dessie, Smits Evelien, Lion Eva, Tel Jurjen, Anguille Sébastien |
| 121686 |
CLINICAL MEDICINE : JOURNAL OF THE ROYAL COLLEGE OF PHYSICIANS OF LONDON |
Seminars in liaison psychiatry, 2nd edn |
2013-02-01 |
10.7861/clinmedicine.13-1-111 |
Negus R. |
| 121685 |
ONCOIMMUNOLOGY |
Effector memory regulatory T-cell expansion marks a pivotal point of immune escape in myelodysplastic syndromes. |
2013-02-01 |
10.4161/onci.22654 |
Mailloux Adam W., Epling-Burnette Pearlie K. |
| 121684 |
DISEASE MODELS & MECHANISMS : DMM |
Transmembrane voltage potential is an essential cellular parameter for the detection and control of tumor development in a Xenopus model |
2013-02-01 |
10.1242/dmm.010835 |
Chernet B. T., Levin M. |
| 121683 |
F1000RESEARCH |
Construction and accessibility of a cross-species phenotype ontology along with gene annotations for biomedical research |
2013-02-01 |
10.3410/f1000research.2-30.v1 |
Köhler Sebastian, Doelken Sandra C, Ruef Barbara J, Bauer Sebastian, Washington Nicole, Westerfield Monte, Gkoutos George, Schofield Paul, Smedley Damian, Lewis Suzanna E, Robinson Peter N, Mungall Christopher J |
| 121682 |
CLINICAL MEDICINE : JOURNAL OF THE ROYAL COLLEGE OF PHYSICIANS OF LONDON |
Modern management of epilepsy |
2013-02-01 |
10.7861/clinmedicine.13-1-84 |
Leach J., Abassi H. |
| 121681 |
ONCOIMMUNOLOGY |
Expression patterns of chemokine receptors on circulating T cells from myelodysplastic syndrome patients. |
2013-02-01 |
10.4161/onci.23138 |
Sand Kristoffer Evebø, Rye Kristin Paulsen, Mannsåker Bård, Bruserud Øystein, Kittang Astrid Olsnes |
| 121680 |
CLINICAL MEDICINE : JOURNAL OF THE ROYAL COLLEGE OF PHYSICIANS OF LONDON |
What lies beneath the surface? |
2013-02-01 |
10.7861/clinmedicine.13-1-103 |
Llewellyn R., Scott S., Meara N., Salim A. |
| 121679 |
ONCOIMMUNOLOGY |
Phase I clinical trial combining imatinib mesylate and IL-2 : HLA-DR + NK cell levels correlate with disease outcome |
2013-02-01 |
10.4161/onci.23080 |
Chaput Nathalie, Flament Caroline, Locher Clara, Desbois Mélanie, Rey Annie, Rusakiewicz Sylvie, Poirier-Colame Vichnou, Pautier Patricia, Le Cesne Axel, Soria Jean-Charles, Paci Angelo, Rosenzwajg Michelle, Klatzmann David, Eggermont Alexander, Robert Caroline, Zitvogel Laurence |
